RHIEOS Ventures and Sickle Cell Foundation Nigeria Announce partnership on HEMA-Global to improve Sickle Cell Access, Care, and Financing in Africa

Blood connects us.  Care unites us.  Reach one.  Restore all.


LAGOS / LONDON, 19 June 2026 — RHIEOS Ventures and Sickle Cell Foundation Nigeria (SCFN) today announced HEMA-Global, an Africa-focused initiative to strengthen sickle cell diagnosis, access to medicines, care coordination, and sustainable financing, anchored first in Nigeria. The launch, on World Sickle Cell Day, also opens Reach One for SCD, a public campaign inviting patients, families, clinicians, diaspora networks, and institutions to take one practical action to help care reach further.

In Nigeria and across Africa, a child is born with sickle cell disease roughly every few minutes, yet most are diagnosed only when a serious crisis strikes. The medicines and care that could reduce pain, prevent complications, and extend life already exist — what has been missing is the system to deliver them and the financing to sustain it.

Across sub-Saharan Africa, an estimated 8.85 million children live with sickle cell disease, at an annual economic cost of USD 9.1 billion, projected to rise to USD 10.2 billion by 2030 (Economist Intelligence Unit). In Nigeria, families bear the bulk of this burden directly: the median monthly cost per patient is approximately $385, and children with SCD miss 20–40 school days a year to pain crises and hospitalization.

HEMA-Global builds on eight years of partnership between RHIEOS Ventures and SCFN, who launched the Sickle Cell Disorder Registry Nigeria (SCDRN) in 2019. The registry has shown that the mean age at first diagnosis is 45 months, and that 76% of enrolled patients have been hospitalized — gaps that earlier screening could close.

As a first concrete step, HEMA-Global will raise funds to support SCFN in expanding newborn screening and patient follow-up, with an ambition of growing the SCDRN from 1,915 to 5,000 registered patients within three to five years, alongside training of genetic counsellors and a comprehensive cohort study.

“For over thirty years, the Sickle Cell Foundation Nigeria has worked so that people living with sickle cell disorder can survive and thrive,” said Dr. Annette Akinsete, CEO/National Director of SCFN. “HEMA-Global gives us a framework to take that change further, state by state across Nigeria and beyond.”

The HEMA-Global Health Financing Challenge, a call for philanthropic, diaspora, and institutional co-investment, is expected to be announced in Q4 2026.

Reach One for SCD opens today at reachoneforscd.org: Blood connects us. Care unites us. Reach one. Restore all. Media: Caleb Anthony Audu, SCFN, caudu@sicklecellfoundation.com; Larry Ajuwon, RHIEOS Ventures, info@rhieosventures.co.uk.

Leave Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

grandpashabet girişgrandpashabet girişdeneme bonusudeneme bonusu veren bahis sitelerideneme bonusu 2026grandpashabet girişGrandpashabetgrandpashabetgrandpashabet deneme bonusugrandpashabet deneme bonusudeneme bonusuGrandpashabetgrandpashabet girişgrandpashabetgrandpashabet güncel girişbahis siteleribahis siteleriGrandpashabet girişjojobetjojobet girişjojobetjojobet girişjojobet girişjojobetjojobet